Organon & Co. Price Today
Organon & Co.
OGN
Healthcare
$5.49B
๐ฐ
Market Cap
7.3
๐ธ
Price to Earnings
$3.0
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
1 |
Hold |
5 |
Sell |
1 |
Strong Sell |
0 |
OGN Price Forecast Target
21.5 ๐ 43.0 +100%
OGN EPS Forecast
3.0 ๐ 4.6 +56%
Financials
Profit Margin
12 %
Revenue Growth
-1.9 %
Dividend
$ 1.12
Held Percent
0.1% - Insiders
79.8% - Institutions
20.1% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $745.0M
-
๐ฐ Blackrock Inc. $381.7M
-
๐ฐ Mawer Investment Management Ltd. $312.2M
-
๐ฐ State Street Corporation $301.8M
-
๐ฐ Massachusetts Financial Services Co. $196.7M
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples aโฆJim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, ChโฆGeorge Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the worldโฆCharlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and โฆ๐ฎFAQ
Some Frequently Asked Questions.
The Organon & Co. industry is Drug ManufacturersโGeneral
The Organon & Co. sector is Healthcare
The Organon & Co. forecasted predicted Price to Earnings PE ratio is 4.7
The Organon & Co. Price to Earnings PE ratio is 7.3
The Market Capitalization of Organon & Co. is $5.49B
There are total of 254689357 float shares with 79.8% held by Institutions and 0.1% held by insiders
The MOrganon & Co. forecasted Earnings per Share EPS is $4.6
The Organon & Co. Earnings per Share EPS is 3.0
The Organon & Co. company has $3889000000 gross profits with 12 profit margins
The Organon & Co. Earnings Growth is -0.493% with -0.491% quarterly earnings growth
The Organon & Co. Revenue is $6144999936 with -0.019 revenue growth
The price target for Organon & Co. stock is $43.0 for the high target and $23.0 for the low target
The consensus analyst recommendations for Organon & Co. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Organon & Co. is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
The Beta of Organon & Co. is 0.8
The dividend of Organon & Co. is $1.12
The dividend yield of Organon & Co. is 0.051999997%
The biggest institutional and mutual fund holders of Organon & Co. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Mawer Investment Management Ltd.
- State Street Corporation
The Organon & Co. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0